CE Medicus

Links

Late Effects of Cancer Treatment and Survivorship
Strategies for Primary Care and Oncology Care Providers

FEATURED ACTIVITY - Now Available

This educational program has been designed to promote provider understanding regarding late effects of cancer treatment and survivorship and their role in long-term surveillance in order to reduce adverse health outcomes of cancer survivors.

After completing this activity, the participant should be better able to

Describe national trends and information related to late effects of cancer treatment and survivorship for pediatric and adult populations.
Assess survivorship medical and psychosocial issues.
Recognize providers' role/opportunity in monitoring and managing pediatric and adult patients' late effects.
Understand long-term follow-up guidelines that provide recommendations for screening and management of late effects that may potentially arise as a result of therapeutic exposures used during cancer.
Manage strategies/issues surrounding transition of care to primary care after discharge from cancer treatment.
Understand the importance of communication between primary care and oncology care providers and potential barriers such as socioeconomic disparities.

Available Formats

Multimedia Slides and Audio
*Macromedia Flash Required

Printable PDF with Transcript
*Adobe Acrobat Reader Required

Faculty Information

Patricia A. Ganz, MD
Professor
David Geffen School of Medicine at UCLA
UCLA School of Public Health
Jonsson Comprehensive Cancer Center
Los Angeles, California

Lisa Diller, MD
Medical Director
Perini Family Survivor's Center
Dana-Farber Cancer Institute
Clinical Director of Pediatric Oncology
Dana-Farber Cancer Institute and Children's Hospital
Boston, Massachusetts

Betty Ferrell, RN, PhD, FAAN
Research Scientist
City of Hope National Medical Center
Duarte, California


	Activity Information
	Release Date: September 15, 2007 Expiration Date: August 31, 2009 Credit Hours: 3

Accreditation

Accreditation
This activity offers the following accreditations:
ACCME, CBRN


	Support Information
	Presented by Blue Cross of California is an independent licensee of the Blue Cross Association. Supported by Late Effects of Cancer Treatment Strategies for and Survivorship: Primary Care Providers for Oncology Care Providers is supported in part by educational grants from the following: American Cancer Society, Amgen Inc, Astra Zeneca, Blue Cross of California, Bristol-Myers Squibb Company, Genentech Inc, John Wayne Cancer Foundation, Lance Armstrong Foundation, Merck and Co. Inc, Pharmion Corporation, Sanofi-Aventis and the Wellpoint Foundation. This activity is endorsed by the Northern California Cancer Center.